【24h】

Newcastle disease: evolution of genotypes and the related diagnostic challenges.

机译:新城疫:基因型的演变和相关的诊断挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

Since the discovery of Newcastle disease virus (NDV) in 1926, nine genotypes of class I viruses and ten of class II have been identified, representing a diverse and continually evolving group of viruses. The emergence of new virulent genotypes from global epizootics and the year-to-year changes observed in the genomic sequence of NDV of low and high virulence implies that distinct genotypes of NDV are simultaneously evolving at different geographic locations across the globe. This vast genomic diversity may be favored by the large variety of avian species susceptible to NDV infection and by the availability of highly mobile wild bird reservoirs. The genomic diversity of NDV increases the possibility of diagnostic failures, resulting in unidentified infections. Constant epidemiological surveillance and pro-active characterization of circulating strains are needed to ensure that the immunological and PCR reagents are effective in identifying NDV circulating worldwide. For example, in the United States, the widely used real-time reverse transcription polymerase chain reaction (RRT-PCR) matrix gene assay for the identification of NDV often fails to detect low virulence APMV-1 from waterfowl, while the RRT-PCR fusion gene assay, used to identify virulent isolates, often fails to detect certain virulent NDV genotypes. A new matrix-polymerase multiplex test that detects most of the viruses currently circulating worldwide and a modified fusion test for the identification of virulent pigeon viruses circulating in the U.S. and Europe have recently been developed. For newly isolated viruses with unknown sequences, recently developed random priming sequencing methods need to be incorporated into the diagnostic arsenal. In addition, the current system of classifying NDV into genotypes or lineages is inadequate. Here, we review the molecular epidemiology and recent diagnostic problems related to viral evolution of NDV and explain why a new system, based on objective criteria, is needed to categorize genotypes.
机译:自从1926年发现新城疫病毒(NDV)以来,已经确定了9种I类病毒基因型和10种II类基因型,它们代表了一组不断变化的病毒。来自全球流行病的新的有毒基因型的出现以及在低毒力和高毒力的NDV基因组序列中观察到的逐年变化表明,NDV的不同基因型在全球不同地理位置同时发展。这种巨大的基因组多样性可能受到易受NDV感染的多种禽类以及高度易流动的野生鸟类储库的青睐。 NDV的基因组多样性增加了诊断失败的可能性,从而导致无法确定的感染。需要对流行株进行持续的流行病学监测和前瞻性表征,以确保免疫学和PCR试剂能有效鉴定全世界正在传播的NDV。例如,在美国,用于鉴定NDV的广泛使用的实时逆转录聚合酶链反应(RRT-PCR)基质基因测定法通常无法从水禽中检测出低毒力APMV-1,而RRT-PCR融合用于鉴定强毒分离株的基因检测通常无法检测到某些强毒NDV基因型。最近开发了一种新的基质-聚合酶多重测试,可以检测目前在世界范围内传播的大多数病毒,以及一种改进的融合测试,用于识别在美国和欧洲传播的强力鸽子病毒。对于具有未知序列的新分离的病毒,最近开发的随机引物测序方法需要纳入诊断库中。另外,当前将NDV分类为基因型或谱系的系统是不足的。在这里,我们回顾了与NDV病毒进化有关的分子流行病学和最近的诊断问题,并解释了为什么需要基于客观标准的新系统来对基因型进行分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号